Products
15201 Results
| Quick actions | ISIN | UL | Product | Direction | SL | Ref. | Bid | Spread | Ask | Ratio | % day | % week | % month | Issue date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Newmont Constant Leverage with ISIN code: CH1450968750 | Newmont | Constant Leverage | Long | ― | 105.264 | 0.84 | 0.050 | 0.89 | 1 | -4.55% | 71.43% | 394.12% | 21 Aug. 2025 | |
| Nike Constant Leverage with ISIN code: CH1362350402 | Nike | Constant Leverage | Long | ― | 57.342 | 0.6 | 0.020 | 0.62 | 1 | -3.23% | -49.58% | -38.78% | 12 Aug. 2024 | |
| Nokia Constant Leverage with ISIN code: CH1450970210 | Nokia | Constant Leverage | Long | ― | 5.511 | 3.31 | 0.080 | 3.39 | 1 | -2.36% | 32.40% | 35.66% | 3 Nov. 2025 | |
| Nokia Constant Leverage with ISIN code: CH1119067226 | Nokia | Constant Leverage | Long | ― | 5.511 | 1.32 | 0.030 | 1.35 | 1 | -2.22% | 12.82% | 16.81% | 6 May. 2022 | |
| Nokia Constant Leverage with ISIN code: CH1450969105 | Nokia | Constant Leverage | Long | ― | 5.511 | 42.66 | 1.020 | 43.68 | 1 | -2.34% | 33.06% | 36.29% | 21 Aug. 2025 | |
| Novartis Constant Leverage with ISIN code: CH1423416671 | Novartis | Constant Leverage | Long | ― | 109.761 | 17.87 | 0.360 | 18.23 | 1 | -1.97% | 26.11% | 99.89% | 12 May. 2025 | |
| Novartis Constant Leverage with ISIN code: CH1276587271 | Novartis | Constant Leverage | Long | ― | 109.761 | 12.64 | 0.110 | 12.75 | 1 | -0.86% | 8.13% | 28.59% | 13 Oct. 2023 | |
| Novartis Constant Leverage with ISIN code: CH1276587305 | Novartis | Constant Leverage | Long | ― | 109.761 | 1.16 | 0.030 | 1.19 | 1 | -2.52% | 20.83% | 75.76% | 13 Oct. 2023 | |
| Novartis Constant Leverage with ISIN code: CH1276587289 | Novartis | Constant Leverage | Long | ― | 109.761 | 8.52 | 0.100 | 8.62 | 1 | -1.16% | 12.25% | 44.90% | 13 Oct. 2023 | |
| Novartis Constant Leverage with ISIN code: CH1276587297 | Novartis | Constant Leverage | Long | ― | 109.761 | 3.92 | 0.070 | 3.99 | 1 | -1.75% | 16.67% | 61.32% | 13 Oct. 2023 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1450968495 | Novo Nordisk | Constant Leverage | Long | ― | 328.458 | 0.13 | 0.030 | 0.16 | 1 | -18.75% | 51.16% | 64.56% | 21 Aug. 2025 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1450968487 | Novo Nordisk | Constant Leverage | Long | ― | 328.458 | 3.09 | 0.040 | 3.13 | 1 | -1.28% | 47.85% | 66.13% | 21 Aug. 2025 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1290993042 | Novo Nordisk | Constant Leverage | Long | ― | 328.458 | 0.009 | ― | ― | 1 | 0.00% | 0.00% | 0.00% | 23 Feb. 2024 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1290993299 | Novo Nordisk | Constant Leverage | Long | ― | 328.458 | 0.009 | ― | ― | 1 | 0.00% | 0.00% | 0.00% | 11 Mar. 2024 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1450968479 | Novo Nordisk | Constant Leverage | Long | ― | 328.458 | 6.54 | 0.060 | 6.6 | 1 | -0.91% | 32.66% | 48.64% | 21 Aug. 2025 | |
| Nvidia Constant Leverage with ISIN code: CH1119068000 | Nvidia | Constant Leverage | Long | ― | 189.096 | 139.51 | 0.280 | 139.79 | 1 | -1.83% | 42.28% | 2.24% | 12 May. 2022 | |
| Nvidia Constant Leverage with ISIN code: CH1199369815 | Nvidia | Constant Leverage | Long | ― | 189.096 | 18.08 | 0.040 | 18.12 | 1 | -2.27% | 54.79% | 1.23% | 27 Jun. 2022 | |
| Nvidia Constant Leverage with ISIN code: CH1246614460 | Nvidia | Constant Leverage | Long | ― | 189.096 | 2.39 | 0.010 | 2.4 | 1 | -2.85% | 67.13% | -0.83% | 3 Feb. 2023 | |
| Nvidia Constant Leverage with ISIN code: CH1246615640 | Nvidia | Constant Leverage | Long | ― | 189.096 | 0.44 | 0.010 | 0.45 | 1 | -4.35% | 57.14% | -2.22% | 8 Jun. 2023 | |
| Nvidia Constant Leverage with ISIN code: CH1423415673 | Nvidia | Constant Leverage | Long | ― | 189.096 | 37.94 | 0.160 | 38.1 | 1 | -4.53% | 127.05% | -16.63% | 7 May. 2025 |
The underlying prices shown are not real-time prices, i.e. they are delayed due to legal requirements of the data provider. As a consequence, the price of the product on a specific underlying may substantially differ from the price of the product that you would expect on the basis of the underlying price displayed.